State Device Inspections Contracts Will Not Be Renewed By FDA
This article was originally published in The Gray Sheet
FDA's device facility inspection contracts with California, Texas and Colorado will not be renewed following their expiration this year because of budget constraints, agency staffers say.
You may also be interested in...
Device quality system inspections performed by state health officials instead of FDA are increasing under a revived program
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.